Physician

Gary Scott Karlin, MD

According to 2025 Medicare claims, Gary Karlin, MD (NPI: 1457334575) practices urology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 08648-2320. Karlin is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Karlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 664 traditional Medicare patients, billed 40,067 HCPCS/CPT codes, and received $309,422 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,096 prescription claims across 745 beneficiaries totaling $1,572,707 in drug costs, led by Xtandi (Enzalutamide). DME data shows 68 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $406,412 and ending at $309,422. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $359,173 to $1,572,707. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $834 and ending at $1,203.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,232	22,382	$406,412
2016	1,278	27,957	$412,843
2017	883	33,383	$397,773
2018	894	38,857	$423,028
2019	797	35,114	$456,535
2020	649	31,090	$658,714
2021	676	39,311	$418,103
2022	677	40,042	$406,632
2023	676	46,690	$499,073
2024	664	40,067	$309,422

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	540	1,815	$359,173
2016	549	1,772	$391,369
2017	582	1,957	$457,453
2018	642	2,117	$1,011,134
2019	652	2,236	$1,392,519
2020	589	2,106	$1,645,511
2021	613	2,294	$1,548,567
2022	649	2,476	$1,407,739
2023	731	2,845	$1,555,101
2024	745	3,096	$1,572,707

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	130	$42,845
2016	13	213	$54,363
2017	N/R	196	$60,372
2018	N/R	156	$65,787
2019	N/R	97	$42,429
2020	N/R	91	$40,187
2021	N/R	68	$45,892
2022	N/R	57	$45,531
2023	N/R	65	$53,769
2024	N/R	68	$60,626

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	195	335	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	488	823	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	241	312	$13
81002	Urinalysis, manual test	228	286	$3
81003	Automated urinalysis test	391	674	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	68	2,040	$947,219
Myrbetriq	Mirabegron	239	14,910	$210,447
Gemtesa	Vibegron	132	8,842	$135,298
Abiraterone Acetate	Abiraterone Acetate	41	1,320	$68,956
Tamsulosin Hcl	Tamsulosin Hcl	738	59,880	$12,507

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	21	$47,921
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	33	$12,366
A4332	Lubricant, individual sterile packet, each	N	N/R	14	$339

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Gary Scott Karlin, MD?

Tedicare shows public-source Medicare data for Gary Scott Karlin, MD (NPI 1457334575), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gary Scott Karlin, MD have ACO affiliation data?

Gary Scott Karlin, MD is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Gary Scott Karlin, MD?

Gary Scott Karlin, MD is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Gary Scott Karlin, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.